Hisato Takagi e Takuya Umemoto
Especificidade das reduções de eventos cardiocerebrais no estudo Kyoto Heart e Jikei Heart
The Kyoto Heart Study was a prospective randomized open blinded end-point (PROBE)-design trial, in which 3031 Japanese patients (mean, 66 years) with uncontrolled hypertension were randomized to either valsartan add-on or non-angiotensin receptor blocker (ARB ) tratamento.
English 
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Hindi